[1]孙阳,李松哲,孙悦,等.贞术消积汤治疗原发性肝癌组方浅析[J].西部中医药,2023,36(07):72-74.[doi:10.12174/j.issn.2096-9600.2023.07.17]
　SUN Yang,LI Songzhe,SUN Yue,et al.Brief Analysis of Zhenzhu Xiaoji Tang in the Treatment of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(07):72-74.[doi:10.12174/j.issn.2096-9600.2023.07.17]
点击复制

贞术消积汤治疗原发性肝癌组方浅析
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年07期
页码:
72-74
栏目:
出版日期:
2023-07-15

文章信息/Info

Title:
Brief Analysis of Zhenzhu Xiaoji Tang in the Treatment of Primary Liver Cancer
作者:
孙阳, 李松哲, 孙悦, 孙敏
黑龙江中医药大学基础医学院，黑龙江 哈尔滨 150040
Author(s):
SUN Yang, LI Songzhe, SUN Yue, SUN Min
Basic Medicine College, Heilongjiang University of Chinese Medicine, Harbin 150040, China
关键词:
原发性肝癌; 贞术消积汤; 组方原则
Keywords:
primary liver cancer; the principles of formulating prescription
分类号:
R273
DOI:
10.12174/j.issn.2096-9600.2023.07.17
文献标志码:
A
摘要:
对贞术消积汤的组方原则和各药研究进展进行综述，指出贞术消积汤为临床经验方，该方立足于本虚标实的总体病机与临床诊治经验，选用女贞子、莪术为君，夏枯草、白花蛇舌草为臣，甘草佐使，善治阴伤络阻、毒瘀互结型肝癌，以解毒滋阴、通络活血为基本治法，攻补兼施、温寒并用，可缓解肝癌患者术后症状，对于晚期不适宜手术患者具有延长带瘤生存时间，提高生存质量的作用。
Abstract:
By reviewing the principles of formulating prescription of Zhenzhu Xiaoji Tang, and research progress of different herbs, Zhenzhu Xiaoji Tang as clinical empirical prescription, on the foundation of comprehensive pathogenesis of root deficiency and superficial excess, and clinical diagnostic and therapeutic experience, contained Nvzhenzi (Ligustri Lucidi Fructus) and Ezhu (Curcumae rhizoma) as the monarch drugs, Xiakucao (Prunellae spica) and Baihua Sheshecao (Hedyotis diffusa) as the ministerial drugs, as well as Gancao (Glycyrrhizae Radix Et Rhizoma) as the adjuvant drug and messenger drug, good at treating liver cancer of Yin loss and collateral obstruction, intermingled toxin and stagnation pattern, detoxifying and nourishing Yin, dredging the collateral and promoting blood circulation are chosen as the basic therapeutic method to alleviate postoperative symptoms of liver cancer patients by tonification and purgation in combination, using warm-nature and cold-nature drugs simultaneously, the prescription could prolong the survival time with tumor and raise quality of life for advanced patients who are not suitable for the operation.

相似文献/References:

[1]钱丽,华海清△.华海清教授运用中药治疗索拉非尼所致腹泻的经验[J].西部中医药,2013,26(07):40.
　QIAN Li,HUA Haiqing.The Experience of Professor HUA Haiqing Using TCM to Diarrhea Induced by Sorafenib Tosylate[J].Western Journal of Traditional Chinese Medicine,2013,26(07):40.
[2]佘彬,陈雁,张瑞明.张瑞明教授治疗原发性肝癌临床经验初探[J].西部中医药,2018,31(01):30.
　SHE Bin,CHEN Yan,ZHANG Ruiming.Exploration into Professor Zhang Ruiming′s Clinical Experience of Treating Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(07):30.
[3]吴文卓,贺松其△.五运六气禀赋与原发性肝癌的相关性[J].西部中医药,2018,31(11):65.
　WU Wenzhuo,HE Songqi.The Correlation between Primary Liver Carcinoma and Natural Endowment of Five Movements and Six Climates[J].Western Journal of Traditional Chinese Medicine,2018,31(07):65.
[4]陈一贞,陈闯.原发性肝癌中医证型客观化研究进展[J].西部中医药,2023,36(02):146.[doi:10.12174/j.issn.2096-9600.2023.02.34]
　CHEN Yizhen,CHEN Chuang.Research Progress in TCM Syndromes Objectification of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2023,36(07):146.[doi:10.12174/j.issn.2096-9600.2023.02.34]
[5]苏晓鹏,晏军,张潞潞,等.从阳虚体质探讨原发性肝癌的防治[J].西部中医药,2023,36(05):43.[doi:10.12174/j.issn.2096-9600.2023.05.09]
　SU Xiaopeng,YAN Jun,ZHANG Lulu,et al.Discussion on the Prevention and Treatment of Primary Liver Cancer from Yang Deficiency Constitution[J].Western Journal of Traditional Chinese Medicine,2023,36(07):43.[doi:10.12174/j.issn.2096-9600.2023.05.09]

备注/Memo

备注/Memo:
孙阳（1979—），女，博士学位，博士后，教授。研究方向：中医药抗肿瘤、抗突变机制研究。国家自然科学基金青年基金（81704054）。
更新日期/Last Update: 2023-07-15